CSI Market
Sign In | Register

Theravance Biopharma inc (TBPH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TBPH Annual Balance Sheets →
The data below summarizes Theravance Biopharma inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent219.77
Cash, Cash Equivalents Other158.78
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments377.00
Derivatives, Collateral, Regulatory, Deferred2.33
Other Current Assets0.00
Other Prepaid Expense, Current PR8.62
Total Current Assets416.66
Equipment/Property/Plant Net5.17
Long-term investments0.00
Other Assets, Noncurrent75.10
Receivables From Collaboration Partners15.58
Operating Lease Right Of Use Asset23.00
Total Assets469.77
Liabilities
Accounts Payable, Current AC0.65
Employee-related Liabilities, Current AC7.83
Other Liabilities, Current22.29
Accrued Income Taxes, Current TA0.00
Total Current Liabilities30.77
Total Long-term Debt0.00
Other liabilities, Noncurrent149.30
Accrued Clinical And Development Expenses Current2.40
Accrued General And Administrative Expenses2.52
Operating Lease Liability Current10.75
Operating Lease Liability Noncurrent29.75
Future Royalty Payment Contingencies32.80
Unrecognized Tax Benefits Total-
Total Liabilities180.07
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,160.24
Retained Earnings / Accumulated Deficit-870.46
Accumulated Other Comprehensive Income-0.08
Other Equity-0.08
Common Stockholder's Equity289.71
Total Stockholder's Equity289.71
Liabilities & Stockholder's Equity469.77
4 historic quarters locked

Sign in to unlock the full Theravance Biopharma inc balance sheet history.

Sign In Create Free Account

About Theravance Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-093773

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.